Fact.MR projects a 6.4% CAGR through 2036 as medical device OEMs increasingly outsource electronics assembly, design transfer, testing, and regulated manufacturing

ROCKVILLE, Md., September 21, 2026 — The global Electronic Manufacturing Services for Healthcare and Medical Device Market is projected to increase from USD 76.5 billion in 2026 to USD 142.8 billion by 2036, registering a 6.4% CAGR during the forecast period, according to a new analysis by Fact.MR. The market was valued at approximately USD 71.9 billion in 2025, with an absolute opportunity of USD 66.3 billion expected between 2026 and 2036.

The market is being shaped by growing medical device complexity, stricter quality requirements, connected healthcare equipment, and the increasing use of external manufacturing partners. Medical device companies are outsourcing more activities across design transfer, component sourcing, electronics assembly, testing, validation, and production as they seek to control capital expenditure while maintaining documented manufacturing processes.

Get detailed market forecasts, competitive benchmarking, and pricing trends:https://www.factmr.com/connectus/sample?flag=S&rep_id=15969

Integrated Manufacturing Services Lead the Market

Integrated Manufacturing Services are projected to account for 41.0% of the manufacturing service type segment in 2026. The segment benefits from demand for a single qualified partner capable of coordinating engineering transfer, component procurement, regulated assembly, testing, and lifecycle support.

Using an integrated EMS provider can reduce the number of manufacturing interfaces that an OEM needs to qualify and manage. It can also simplify change control when components become obsolete or production processes require modification.

For medical device manufacturers, the ability to connect engineering support with controlled production is becoming increasingly relevant as products move from prototype development into commercial manufacturing.

Diagnostic Devices Represent the Largest Device Category

Diagnostic Devices are expected to hold a 43.0% share of the market by medical device category in 2026. Imaging equipment, laboratory analyzers, monitoring systems, and point-of-care instruments increasingly depend on electronic assemblies, sensors, communication modules, and signal-processing components.

These requirements create demand for EMS providers with capabilities covering PCB assembly, precision electronics, component sourcing, testing, and quality documentation.

As diagnostic devices become more connected and compact, manufacturers must also manage miniaturized components and increasingly dense circuit designs. This is increasing the importance of advanced assembly and inspection technologies.

Hospitals and Medical Device OEMs Drive Demand

Hospitals and healthcare providers are projected to account for 40.0% of the end-use application segment in 2026. Healthcare facilities operate extensive fleets of diagnostic, monitoring, and patient-care equipment, creating recurring demand linked to replacement, technology upgrades, and service continuity.

Medical Device OEMs are expected to represent 42.0% of the customer category in 2026. OEMs retain responsibility for product architecture and regulatory submissions while increasingly relying on external manufacturing specialists for industrialization and production.

This relationship requires EMS providers to translate design specifications into controlled work instructions, validated processes, and traceable manufacturing records.

Advanced Assembly Technology Gains Importance

Advanced Assembly Technology is projected to account for 41.0% of the production technology segment in 2026. Medical electronics increasingly combine miniaturized sensors, dense circuitry, and compact interconnects, requiring precise placement, controlled soldering, and automated inspection.

Automation can also generate machine-based production records that help manufacturers investigate deviations and demonstrate that manufacturing processes remained within specified limits.

The resulting opportunity extends beyond basic contract assembly. EMS providers with design-for-manufacturing, design-for-test, automated inspection, component lifecycle management, and validation capabilities can support OEMs across multiple stages of the product lifecycle.

Regulatory Requirements and Supply Continuity Reshape Outsourcing

Regulatory quality requirements are increasing the importance of qualified manufacturing partners. In the United States, the FDA Quality Management System Regulation became effective on February 2, 2026, incorporating ISO 13485:2016 into medical device current good manufacturing practice requirements.

Medical device companies are also paying greater attention to supply continuity. Component shortages can interrupt production and affect healthcare equipment availability, encouraging OEMs to evaluate suppliers based on multi-site sourcing, component lifecycle management, contingency planning, traceability, and change-control capabilities.

At the same time, cost and complexity remain restraints. Supplier qualification, compliance checks, validation requirements, and revalidation following component changes can increase both manufacturing costs and time to production.

United States Leads the Regional Growth Outlook

The United States is forecast to expand at a 7.3% CAGR from 2026 to 2036, followed by Germany at 7.0% and Japan at 6.7%. China is projected to grow at 6.4%, while the United Kingdom, Canada, and South Korea are forecast at 6.1%, 5.8%, and 5.5%, respectively.

The U.S. market benefits from a large regulated medical device manufacturing base and demand for qualified partners supporting design transfer, assembly, testing, and supply continuity. Germany's medical technology manufacturing ecosystem supports demand for regulated electronics production, while Japan's international regulatory alignment and healthcare technology development create additional opportunities for contract manufacturers.

China's established electronics supply chain provides access to components, printed circuit boards, tooling, and high-volume assembly, while the UK market is supported by continued medical device development and clinical investigation activity.

Analyst Perspective

“Medical device OEMs will select manufacturing partners on evidence of process control, design-transfer capability and supply continuity. Scale is useful, but it does not replace traceability or the ability to maintain validated production after component and design changes. Suppliers that connect engineering support with regulated manufacturing are expected to gain a larger share as the market expands from USD 76.5 billion in 2026 to USD 142.8 billion by 2036,” said Shambhu Nath Jha, Senior Consultant at Fact.MR.

Competitive Landscape

The competitive landscape includes established electronics manufacturing and technology service providers with capabilities spanning component sourcing, PCB assembly, engineering, testing, advanced manufacturing, and regulated production.

Companies profiled in the Fact.MR assessment include Jabil Inc., Flex Ltd., Benchmark Electronics, Inc., Sanmina Corporation, TE Connectivity Ltd., Venture Corporation, Creation Technologies, and Plexus Corp.

Competition is influenced by manufacturing scale, quality-system capabilities, supply-chain resilience, advanced assembly technology, engineering support, geographic coverage, and the ability to maintain controlled production through product and component changes.

Unlock Actionable Insights from the Complete Report: https://www.factmr.com/report/electronic-manufacturing-services-for-healthcare-and-medical-device-market

Report Scope

The Fact.MR study analyzes the Electronic Manufacturing Services for Healthcare and Medical Device Market across manufacturing service type, medical device category, end-use application, customer category, production technology, and region.

Manufacturing services include integrated manufacturing, component manufacturing, design and engineering, and regulated manufacturing services. Medical device categories include diagnostic devices, therapeutic devices, surgical devices, and patient-care equipment.

The study covers North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and the Middle East & Africa, with detailed analysis of the United States, Germany, Japan, China, the United Kingdom, Canada, and South Korea.

Explore More Related Studies Published by Fact.MR Research

Adult Stem Cells Market- https://www.factmr.com/report/adult-stem-cells-market

Cuffless BP Monitor Market- https://www.factmr.com/report/cuffless-bp-monitor-market

DNA Encoded Library Market- https://www.factmr.com/report/dna-encoded-library-market

DNA Repair Drugs Market- https://www.factmr.com/report/dna-repair-drugs-market

About Fact.MR

Fact.MR is a market research and consulting firm providing industry intelligence across healthcare, technology, automotive, food and nutrition, chemicals, consumer goods, and other industries. Its research combines market analysis, primary research, company assessment, market sizing, and forecasting to support strategic business decisions.

Media Contact

Fact.MR
Email: [email protected]
Website: https://www.factmr.com/